Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Collins

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Alcoholism, Clinical and Experimental Research|November 1, 2021
Moderate blood alcohol and brain neurovulnerability: Selective depletion of calcium-independent phospholipase A2, omega-3 docosahexaenoic acid, and its synaptamide derivative as a potential harbinger of deficits in anti-inflammatory reserveJennifer A Schreiber, Nuzhath F Tajuddin, Dimitrios E Kouzoukas, et al.
Journal of Neurochemistry|April 17, 2004
Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptakeAlexander Storch, Yu-I Hwang, Debra A Gearhart, et al.
Plos One|July 17, 2014
Neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acidNuzhath Tajuddin, Kwan-Hoon Moon, S Alex Marshall, et al.
Neurochemistry International|June 29, 2019
PARP inhibition in vivo blocks alcohol-induced brain neurodegeneration and neuroinflammatory cytosolic phospholipase A2 elevationsDimitrios E Kouzoukas, Jennifer A Schreiber, Nuzhath F Tajuddin, et al.
Alcoholism, Clinical and Experimental Research|November 27, 2008
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studiesMichael A Collins, Edward J Neafsey, Kenneth J Mukamal, et al.
Neurotoxicity Research|January 22, 2013
Putative agmatinase inhibitor for hypoxic-ischemic new born brain damageJohn E Piletz, Stephanie Klenotich, Ken S Lee, et al.
Regulatory Toxicology and Pharmacology : RTP|August 9, 2012
Risk assessment for consumer exposure to toluene diisocyanate (TDI) derived from polyurethane flexible foamScott M Arnold, Michael A Collins, Cynthia Graham, et al.
Neurotoxicity Research|August 24, 2011
New strategies in neuroprotection and neurorepairMarta C Antonelli, Gilles J Guillemin, Rita Raisman-Vozari, et al.
Annals of Emergency Medicine|March 29, 2002
The Frontlines of Medicine Project: a proposal for the standardized communication of emergency department data for public health uses including syndromic surveillance for biological and chemical terrorismEdward N Barthell, William H Cordell, John C Moorhead, et al.
Alcoholism, Clinical and Experimental Research|April 29, 2004
Alcohol-induced neurodegeneration: when, where and why?Fulton T Crews, Michael A Collins, Cynthia Dlugos, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Alcoholism, Clinical and Experimental Research|November 1, 2021
Moderate blood alcohol and brain neurovulnerability: Selective depletion of calcium-independent phospholipase A2, omega-3 docosahexaenoic acid, and its synaptamide derivative as a potential harbinger of deficits in anti-inflammatory reserveJennifer A Schreiber, Nuzhath F Tajuddin, Dimitrios E Kouzoukas, et al.
Journal of Neurochemistry|April 17, 2004
Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptakeAlexander Storch, Yu-I Hwang, Debra A Gearhart, et al.
Plos One|July 17, 2014
Neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acidNuzhath Tajuddin, Kwan-Hoon Moon, S Alex Marshall, et al.
Neurochemistry International|June 29, 2019
PARP inhibition in vivo blocks alcohol-induced brain neurodegeneration and neuroinflammatory cytosolic phospholipase A2 elevationsDimitrios E Kouzoukas, Jennifer A Schreiber, Nuzhath F Tajuddin, et al.
Alcoholism, Clinical and Experimental Research|November 27, 2008
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studiesMichael A Collins, Edward J Neafsey, Kenneth J Mukamal, et al.
Neurotoxicity Research|January 22, 2013
Putative agmatinase inhibitor for hypoxic-ischemic new born brain damageJohn E Piletz, Stephanie Klenotich, Ken S Lee, et al.
Regulatory Toxicology and Pharmacology : RTP|August 9, 2012
Risk assessment for consumer exposure to toluene diisocyanate (TDI) derived from polyurethane flexible foamScott M Arnold, Michael A Collins, Cynthia Graham, et al.
Neurotoxicity Research|August 24, 2011
New strategies in neuroprotection and neurorepairMarta C Antonelli, Gilles J Guillemin, Rita Raisman-Vozari, et al.
Annals of Emergency Medicine|March 29, 2002
The Frontlines of Medicine Project: a proposal for the standardized communication of emergency department data for public health uses including syndromic surveillance for biological and chemical terrorismEdward N Barthell, William H Cordell, John C Moorhead, et al.
Alcoholism, Clinical and Experimental Research|April 29, 2004
Alcohol-induced neurodegeneration: when, where and why?Fulton T Crews, Michael A Collins, Cynthia Dlugos, et al.
Pageof 8